CI News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$79.89B

Volume

1.21M

Next Earnings

October 29th

Mkt Cap

$78.96B

Volume

1.21M

Next Earnings

October 29th

Chart Financials Earnings News About Dividends Insider Filings

Here's Why Cigna (CI) is a Strong Growth StockZacks highlights Cigna (CI) as a stock to watch with a #3 (Hold) rank and VGM Score of A. The company shows solid growth prospects with a Growth Style Score of B and forecasted year-over-year earnings growth of 2.3% for the current fiscal year. Two analysts revised earnings estimates higher in the last 60 days, with the consensus estimate increasing to $30.51 per share.Zacks Investment Research · Oct 6, 2026

Should You Buy, Hold or Sell CVS Stock Amid Consumer Wellness Growth?CVS Health's Pharmacy & Consumer Wellness segment showed strong growth with operating income up 10.2% year-over-year to $1.48 billion in Q2 2026, supported by higher prescription volumes and improved margins. The company raised its 2026 operating income outlook for the segment by $220 million. CVS is expanding AI tools including Health100 and Claims Assist Manager to improve efficiency and customer service. However, reimbursement pressure, regulatory scrutiny, and insufficient Medicare Advantage payment updates remain key headwinds. With a discounted valuation (P/S of 0.29X vs. industry average 0.53X), Zacks recommends current holders maintain positions while prospective investors wait for a more favorable entry point.Zacks Investment Research · Sep 10, 2026

BTSG's Specialty Pharmacy Sales Up 30%: Will the Growth Continue?BrightSpring Health Services (BTSG) reported strong Q2 2026 results with Specialty and Infusion revenue growing 30% and scripts rising 31%, driven by branded limited distribution drugs (LDDs) and expansion into rare and orphan therapies. The company added two new LDDs, bringing its portfolio to 155 programs with 12 launched in 2026. Pharmacy Solutions adjusted EBITDA increased 44% to $180 million. Peers Cigna and Humana also showed strength in specialty pharmacy segments, though with different growth drivers.Zacks Investment Research · Sep 10, 2026

Can Cigna's Smart Coverage Help Close Health-Cost Gaps?Cigna Healthcare is introducing Smart Coverage, a new benefit option that automatically links medical claims with supplemental benefits to provide eligible members up to $7,000 for covered health events. The program launches January 1, 2027, for mid-sized employers and addresses a significant affordability gap, with nearly 60% of Americans unprepared for health costs. The initiative is designed to increase enrollment in high-deductible plans and boost supplemental product participation.Zacks Investment Research · Aug 27, 2026

Sale Proposal for The Dolphin Company to Grupo Xcaret Threatens 90% Monopoly and Violates Court RulingsThe Dolphin Company's management has proposed selling its Mexican assets to Delphinus Blue Planet (Grupo Xcaret subsidiary) for $20 million, a deal that would violate Mexican Supreme Court rulings and create a 90% monopoly in dolphin habitat tourism. The proposal was filed in U.S. Bankruptcy Court despite an active judicial stay from Mexico's highest court prohibiting asset sales without authorization.GlobeNewswire Inc. · Jul 28, 2026

Prediction: U.S. Value Stocks Will Outperform for 10 Years. Which ETFs Should You Buy?Vanguard research forecasts that U.S. value stocks and small-cap stocks will outperform growth stocks over the next 10 years. The article compares two Vanguard ETFs for value stock exposure: the Vanguard Small-Cap Value ETF (VBR), a passively managed fund with ultra-low fees, and the Vanguard U.S. Value Factor ETF (VFVA), an actively managed alternative with broader market-cap exposure. Both funds have recently outperformed the S&P 500 and Nasdaq-100.The Motley Fool · Jul 21, 2026

Modern Therapy Group launches virtual intensive outpatient program for mental healthModern Therapy Group has launched a virtual intensive outpatient program (IOP) for adults with depression, anxiety, trauma, and other mental health conditions. The program offers five days a week of clinician-led telehealth treatment, providing a middle ground between weekly therapy and inpatient care. Available in seven states with in-network coverage from major insurers including Blue Cross Blue Shield, Aetna, Cigna, and Optum/United.GlobeNewswire Inc. · Jun 24, 2026

GILC Convenes World Leaders on Social Connection and Division During Global Loneliness Awareness WeekThe Global Initiative on Loneliness and Connection (GILC) is hosting the Global Connection Forum on June 17, 2026, to address social disconnection as a major public health and economic challenge. The forum will bring together leaders from public health, policy, and philanthropy to explore how social connection can repair polarization and division. Research shows chronic disconnection increases illness risk by 26-28% and costs employers $159 billion annually in lost productivity.GlobeNewswire Inc. · Jun 10, 2026

Cigna Raises Outlook, Flags Individual Exchange Exit And Strategic Review Of eviCoreCigna reported Q1 2026 adjusted earnings of $7.79 per share, beating consensus of $7.61, with sales rising 5% to $68.52 billion. The company raised its full-year adjusted EPS outlook to at least $30.35. However, Cigna announced plans to exit the individual exchange business by year-end and initiated a strategic review of eviCore. CEO David Cordani will transition to Executive Chair, with Brian Ivanko becoming CEO in July 2026.Benzinga · Apr 30, 2026

The Cigna Group Declares Quarterly DividendThe Cigna Group's Board of Directors declared a quarterly cash dividend of $1.56 per share, payable on June 18, 2026, to shareholders of record as of June 4, 2026.Benzinga · Apr 22, 2026

CIThe Cigna Group

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any CI yet.

Related Tickers

Earnings

Dividends

Last · Sep 8Quarterly

Amount$1.56

Yield2.05%

Annual$6.19

Mkt Cap

$79.89B

Volume

1.21M

Next Earnings

October 29th